Criteria category (Revised on April 1, 2024 )source: Japan Society of Ningen Dock and Preventive Medical Care
Item

A: Normal

kg/m 2
Male
Abdominal circumference
cmFemale
Systolic
Blood pressure
mmHg ＊3(2 measurements: average)
DiastolicHeart rate (supine position)
beats/minute
Visual acuity (use corrected vision for judgment if measured
both unaided and corrected) (use worst side for judgment)
1000 Hz
Hearing acuitydB
4000 Hz
Forced expiratory volume %in one second (%)

18.5–24.9
84.9 or less89.9 or less
129 or less84 or less
45–85

Body mass index (BMI)

Respiratory function (spirometry) Forced expiratory volume %Describe down to the firstin 1 second (percentage ofdecimal place ＊4
expected forced expiratory
volume in 1 second)
Percent lung capacity (%)
Total protein
g/dLAlbumin
g/dL ＊5
Creatinine mg/dL
Male(Prioritize eGFR for judgment)(Describe down to the second decimalFemaleplace)2(mL/min/1.73)
eGFRm(Describe down to the first decimal place)
Uric acid
mg/dL
HDL cholesterol
mg/dL
Non-HDL cholesterol
mg/dL ＊6
LDL cholesterolmg/dLTriglyceride
mg/dL ＊7
AST (GOT)U/L
ALT (GPT)U/L
γ -GT ( γ -GTP)
U/L

Fasting blood glucose

0.7–0.9

0.6 or less30 or less30 or less35
35

40 or greater
40 or greater

70.0 or greater

80.0 or greater
6.5–7.9
3.9 or greater
1.00 or less
0.70 or less2.1–7.040 or greater
90–14960–11930–14930 or less30 or less50 or less
FPG:99 or lessandHbA1c:5.5 or lessWhite blood cell count103 / μ L
MaleFemale

3.1–8.4
13.1–16.3
12.1–14.5

104 / μ L

14.5–32.9Platelet count

CRP
mg/dL
(Describe down to the second decimal place)
Serologic test for syphilis
HBs antigen
HCV antibody
Urine protein
Urine occult blood
Urine sugar
Urinary sediment ＊10
Stool occult blood 2-day method
Day 1, Day 2
Uterine cervical cytology ＊11

Bethesdaclassification

0.30 or less
Negative
Negative
Negative
(−)
(−)
(−)

1.01–1.09

79.9 or less
6.1 or less, 8.4 or greater
3.6 or less
1.30 or greater

0.71–0.79

0.80–0.99

1.00 or greater

45.0–59.9

44.9 or less7.1–7.9

2.0 or less, 8.0–8.9
30–39
170–209140–179
300–499
36–50
41–50
81–1009.0 or greater
29 or less89 or less, 210 or greater
59 or less, 180 or greater
29 or less, 500 or greater
51 or greater
51 or greater
101 or greater

1) FPG:110–125
2) HbA1c:6.0–6.4
3) FPG: 126 or greater, andHbA1c: 6.4 or less
4) FPG: 125 or less and HbA1c:6.5 or greater One of 1) to 4)

FPG: 126 or greaterandHbA1c: 6.5 or greater

9.0–9.9
12.1–13.0
11.1–12.0

3.0 or less, 10.0 or greater
12.0 or less, 18.1 or greater
11.0 or less, 16.1 or greater

10.0–12.2

9.9 or less, 40.0 or greater

150–169
120–139
150–299
31–35
31–4051–80
1) FPG:100–109,
andHbA1c:5.9 or less
2) FPG:99 or less,and
HbA1c:5.6–5.91) or 2)
8.5–8.9
16.4–18.0
14.6–16.0
12.3–14.4,
33.0–39.9
0.31–0.99(±)(±)( ± ) or greater

1.00 or greater(+) ＊9(+) ＊9(−)
NILM

79.9 or less(forced expiratory volume % in
1 second is 69.9% or less)6.2–6.4
3.7–3.8
1.10–1.298.0–8.3

60.0 or greater% ＊8g/dL

69.9 or less
79.9 or less(forced expiratory volume % in
1 second is 70.0% or greater)or80.0 or greater(forced expiratory volume % in
1 second is 69.9% or less)

80.0 or greater(forced expiratory
volume% in
1 second is 70.0% orgreater)

HbA1c

Hemoglobin

130–139
85–89

D: Medical consultation required
C: Requires re-examination and (D1: Treatment needed,
E: On＊
treatment ＊12life improvement 1
D2: Detailed examinationneeded) ＊2
18.4 or less, 25.0 or greater
85.0 or greater
90.0 or greater
140–159
160 or greater
90–99
100 or greater
40–44, 86–99
39 or less, 100 or greater

1.0 or greater

Fasting plasma glucose
mg/dL

B: Slightly abnormal

Positive
Positive
Positive(2+) or greater(2+) or greater(+)
Inadequate
specimen=indeterminate(immediately re-examination)＊＊
11

ASC-US, ASC-H, LSIL, HSIL/
CIN2, HSIL/CIN3, SCC, AGC, AIS,
Adenocarcinoma, Other malig

The classification is to be used as the basis for initial examination. Where a case is judged to require close examination and treatment (judgment D), if the results of the close examination showthat there is no clear cause for the abnormality, that the abnormality is innate, or that the size of the shadow remains the same, it is appropriate to change the judgment to judgment C, etc.,
depending on the details of the results. Even for the initial judgement, it is appropriate to change the judgment category based on age, history of previous examinations, and other factors.
Cancer-related tests should be judged with caution. On the other hand, if cancer is suspected, it should be noted and a medical examination should be strongly recommended.
＊1＊2＊3＊4＊5

The expression of “C: Requires follow-up” will be revised. Clearly state the timing of re-examination such as “in X months” to clearly instruct examinees in the actions they should take.
Imaging and physiological tests may be performed again in 1 year.
No ambiguous descriptions shall be made, such as follow-up, periodical tests, and hospital visit required if any symptom occurs.
The expression of “D: Medical care needed” will be revised. Because the question of whether to perform detailed examination or to give treatment will be decided by the referral site, D1and D2 will be combined. “Detailed examination needed” or “Treatment needed” may be selected according to the high/low values and findings.
For blood pressure, blood pressure measurement at home is recommended rather than repeated tests at a medical institution.
Respiratory function test may be subtly influenced by the relationship between the tester and the subject.
The severity of obstructive disorder will be determined in combination of forced expiratory volume% in 1 second and % forced expiratory volume in 1 second.
Forced expiratory volume% in 1 second of less than 70% and % forced expiratory volume in 1 second of 80% or greater is determined to be mild, and 79% or less is determined to bemoderate or greater.
Obstructive, restrictive, and mixed ventilatory impairment will be determined by combining forced expiratory volume% in 1 second and percent lung capacity.
See below for differences between albumin BCG and modified BCP.
http://www.jslm.org/others/news/20131225albumin.pdf

＊6

In principle, LDL-C should be measured by the direct method, and its determination should be prioritized over that of non-HDL-C.
(1) If triglycerides are 400 mg/dL or higher: do not use the Friedewald method to calculate LDL-C. If triglycerides are 600 mg/dL or higher: do not use the Friedewald method tocalculate LDL-C. When triglycerides are 600 mg/dL or higher, non-HDL-C values are unreliable.
The direct LDL method is also considered unreliable when triglycerides are 1000 mg/dL or higher.
(2) Triglycerides <400 mg/dL: non-HDL-C values are not used for determination; instead, the LDL-C (Friedewald formula or direct method) is used.
LDL-C and HDL-C may be inaccurate when HDL composition significantly differs from normal (HDL-C< 20 mg/dL, ≥ 120 mg/dL, cholestasis, etc.), and other tests such as forapoproteins should be used in retesting, etc. Total cholesterol is used to calculate non-HDL cholesterol, and no independent assessment of total cholesterol is performed.
＊7
Blood shall be withdrawn in the fasting state so not to influence blood glucose and lipid＊8
OGTT is recommended if determined as fasting blood glucose, HbA1c (NGSP) combined category C 1 or 2
If determined as 3 or 4, life style improvement shall be instructed, and its result shall be re-evaluated in a short period.
＊9If urine protein is (+) and urine occult blood is (+), urine protein will be determined as D.
＊10 For urinary sediment, see the table on criteria category in the attached table.
＊11 Brush, spatula, and cyto-pick etc. shall be used as a sampling equipment instead of swabs; sample shall be stored using liquid-based cytology (LBC) if possible
Cervical cytology specimens shall be only collected by a physician. Self-collection is not allowed.
＊＊11 Inadequate specimens shall be promptly re-examined. Patients with ASC-US will receive an HPV-DNA test or repeated cytology 6 months and 12 months later, or receive a detailed
examination by colposcopy.
＊12 Determine as E if on treatment＊＊
Standard range of intraocular pressure is 9-20 mmHg, and 70 percent of glaucoma is within this range; therefore, criteria category is not set＊＊
Up to moderate increase of total bilirubin will be proportionate to the reduction of mortality, and will be a prevention for arteriosclerosis; therefore, criteria category is not set＊＊
Measurement of ALP was changed from the JSCC method to the IFCC method in FY 2020 . As a result, the influence of blood type is reduced but remains, whereas the influence ofmenopause is as strong as before. Accordingly, an ALP determination category will not be created, as previously. (August 2023 Board of Directors meeting)
Reference: http://jscc-jp.gr.jp/file/2019/alpld2.pdf/http://jscc-jp.gr.jp/file/2019/alpld4.pdf＊＊
See the Japan Society of Ningen Dock and Preventive Medical Care website for the screening decision manual on images from chest X-ray, upper gastrointestinal tract X-ray, uppergastrointestinal endoscopy, abdominal ultrasound, electrocardiogram, and fundus.

Urinary Sediment Criteria Category
Type
Red blood cells ＊White blood cells

Description
CriteriaA
Observed in some renal and urinary tract diseases and systemic bleeding diseases.
C–DLess than 5/HPF
Determination is made based on the calculated count (same hereinafter).
Observed in urinary tract bacterial infections.

Renal tubularRenal tubular epithelial cells detached in the kidney and often observed in kidney
epithelial cells
diseases.
Urothelial epithelial Cells detached from a part of the kidney to a part of the ureter, bladder, andcells
urethra.
Squamous epithelial
Epithelial cells detached from around the external urethral orifice.
cells
Oval fat body
Intracytoplasmic
inclusion-bearing
cells
Intranuclear
inclusion-bearing
cells
Atypical cells
Casts
Hyaline casts
Epithelial cell casts
Granular casts
Waxy casts
Fatty casts
RBC casts
WBC casts
Vacuolardenatured casts
Salt/crystal casts
Bacteria
FungusProtozoa

B

B–D

Less than 5/HPF

D

Less than 1/HPF

B

Less than 1/HPF

1-/HPF
1-/HPFC

D

5-9/HPF

10-/HPF
10-/HPFWhen there is a clinical symptom inthe urinary tract

5-9/HPF

1-/HPF

B

Less than 1/HPF

Cells containing fat granules that appear in association with renal diseases such as
nephrotic syndrome.

D

0/WF

1-/WF

Degenerative cells that appear during inflammation of the urinary system.

DLess than 1/HPF

1-/HPF

Cells that develop in association with DNA viral infections caused by herpes virus,
cytomegalovirus, etc.

D0/WF

1-/WF

D0/WF

1-/WF

B–C

0/WF

D0/WF

1-/WF

D0/WF

1-/WF

D0/WF

1-/WF

D0/WF

1-/WF

D0/WF

1-/WF

D0/WF

1-/WF

D0/WF

B

0/WF

1-/WF

B

̶

1+ or greaterB̶

1+ or greaterD̶Cells that may be suggestive of cancer.
Particles with paralleled margins with rounded ends. They are an indicator ofkidney disease. Casts have many types as follows:
A kind of protein accumulated in the renal tubular lumen. May be found even inhealthy individuals after heavy exercise.
Casts which enclose renal tubular epithelial cells detached from the renal tubulesby damage.
Casts which enclose granular components derived from degenerated cells.
Thick casts formed after granular casts have gradually disintegrated due to longterm obstruction of the renal tubular lumen. May be found in chronic renal failure.
Casts containing fat granules and oval fat bodies. They are found at high urine
protein levels.
Casts containing red blood cells that are often seen when bleeding occurs in thekidneys (glomerulus).
Casts containing a large amount of white blood cells and which may be associatedwith glomerulonephritis and pyelonephritis.
Casts often containing small and large vacuoles. Often found in severe diabetic
nephropathy.
Casts enclosing phosphate, uric acid salts, crystals of calcium oxalate, etc.
Presence of bacteria suggests urinary tract infection. Not problematic if no whiteblood cells are found at the same time.
Type of mold that disappears without any special treatment, but requires caution
if the patient has diabetes or other conditions with decreased immune function.
Some protozoa such as trichomonas cause sexually transmitted diseases.
Treatment is required.

1-4/WF

5-/WF

1-/WF

1+ or greater＊ If the determination of urinary occult blood and that of urinary red blood cells differ, priority shall be given to the determination of urinary red blood cells. At the time of complete medical

checkup, it is not necessary to distinguish between glomerular and non-glomerular red blood cells, although it is preferrable to distinguish them at the time of re-examination/detailed
examination.
Abbreviations: HPF (high power field), WF (whole field)